Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes

Immune checkpoint inhibitors (ICIs), particularly inhibitors of the PD-1 axis, have altered the management of non-small cell lung cancer (NSCLC) over the last ten years. First demonstrated to improve outcomes in second-line or later therapy of advanced disease, ICIs were shown to improve overall sur...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Cancer Res
Hoofdauteurs: Doroshow, Deborah B., Sanmamed, Miguel F., Hastings, Katherine, Politi, Katerina, Rimm, David L., Chen, Lieping, Melero, Ignacio, Schalper, Kurt A., Herbst, Roy S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6679805/
https://ncbi.nlm.nih.gov/pubmed/30824587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-1538
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items